Aug
01
Quality measures are standards for measuring the performance of health care providers to care for patients and populations. PQA develops and stewards measures focused on medication use.
Filtered by category: Performance Measurement Clear Filter
Jun
01
PQA follows a systematic, transparent and consensus-based development process to ensure that measures are important, scientifically acceptable, feasible and usable. This approach produces strong, consistent results, but it also takes time.
Read More
PQA Appoints 17 Individuals to Serve on Health Plan PDC Composite Measure TEP
Category: Performance Measurement
Apr
27
PQA has appointed 17 individuals from member organizations to serve on a technical expert panel (TEP) to review and provide input on draft specifications for a health plan measure concept: Proportion of Days Covered (PDC) Composite.
Read More
Apr
20
PQA follows a systematic, transparent and consensus-based development process to ensure that measures are important, scientifically acceptable, feasible and usable. This approach produces strong, consistent results, but it also takes time.
Read More
Mar
29
PQA has published the 2022 PQA Measure Manual and Value Sets. The PQA Measure Manual includes detailed narrative specifications for PQA measures, which are needed to implement the measures accurately and appropriately. PQA Value Sets, which include National Drug Codes (NDCs), are required to calculate PQA measures as specified.
Read More
Mar
22
The Pharmacy Quality Alliance (PQA) seeks interested pharmacy and payer partners to participate in proof-of-concept pilots to implement high priority blood pressure and hemoglobin A1c measure concepts in value-based payment arrangements (VBAs).
Read More
Dec
16
Prescription opioid-related deaths are one of the leading preventable public health problems. High-risk prescribing practices have contributed to the opioid overdose epidemic. These include overlapping opioid and benzodiazepine prescriptions, prescribing high-dose opioids and using multiple prescribers or pharmacies for opioid prescriptions.
Read More
PQA and CPF Lead National Initiative to Prioritize Pharmacy Measure Concepts
Category: Performance Measurement
Nov
19
Concepts Could Be Used in Payer-Pharmacy Value-Based Arrangements
Read More
Developing the Right Measures Begins with Effective Conceptualization
Category: Performance Measurement
Nov
03
PQA follows a systematic, transparent and consensus-based development process to ensure that measures are important, scientifically acceptable, feasible and usable. This approach produces strong, consistent results, but it also takes time.
Read More
Aug
20
This fall and into 2022, there are numerous opportunities for PQA members to participate in our measure development process. As a consensus-based and member-driven organization, this is the moment for you and your organization to inform and influence decisions on measures across the development and stewardship continuum. Here's what's coming up soon. Information on each of these will be emailed to members as we get closer to the opportunity.
Read More
Mar
10
PQA endorsed two new diabetes-focused health plan performance measures in December 2020. More than 34 million Americans have diabetes, according to the Centers for Disease Control and Prevention. These measures will help evaluate the quality of care for a disease that annually costs America $327 billion.